Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.

Twenty-seven patients with disseminated malignant melanoma were treated monthly with cisplatin (CDDP) 120 mg m-2 on day 1, vindesine (VDS) 3 mg m-2 on day 2 and dacarbazine (DTIC) 250 mg m-2 on days 2-6. None of them had received prior chemotherapy. All patients are evaluable for response and toxici...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pectasides, D., Yianniotis, H., Alevizakos, N., Bafaloukos, D., Barbounis, V., Varthalitis, J., Dimitriadis, M., Athanassiou, A.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1989
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2247122/
https://ncbi.nlm.nih.gov/pubmed/2803936
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires